Log in to save to my catalogue

Medicare part D prescribing for direct oral anticoagulants in the United States: Cost, use and the “...

Medicare part D prescribing for direct oral anticoagulants in the United States: Cost, use and the “...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_2051643550

Medicare part D prescribing for direct oral anticoagulants in the United States: Cost, use and the “rubber effect”

About this item

Full title

Medicare part D prescribing for direct oral anticoagulants in the United States: Cost, use and the “rubber effect”

Publisher

United States: Public Library of Science

Journal title

PloS one, 2018-06, Vol.13 (6), p.e0198674-e0198674

Language

English

Formats

Publication information

Publisher

United States: Public Library of Science

More information

Scope and Contents

Contents

Direct oral anticoagulants (DOAC) have gained an increased share over warfarin for prevention and treatment of thromboembolic disease. We studied DOAC adoption across providers and medical specialties.
Retrospective, cross-sectional analysis of Medicare Part D public use files (PUF), 2013 to 2015. We summarized prescription data for claims and d...

Alternative Titles

Full title

Medicare part D prescribing for direct oral anticoagulants in the United States: Cost, use and the “rubber effect”

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_plos_journals_2051643550

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_2051643550

Other Identifiers

ISSN

1932-6203

E-ISSN

1932-6203

DOI

10.1371/journal.pone.0198674

How to access this item